Antimicrobial Targets, Resistance Mechanisms and Selective Toxicity
A useful drug hits something the microbe has and we do not, such as the wall, the ribosome or a folate enzyme. Resistance arises by changing the target, destroying the drug, pumping it out or keeping it from entering, and the drug does not create those changes but selects for them.
What a learner can do afterwards
- Matches a drug class to its target and explains what makes that target selective.
- Names four resistance mechanisms and gives an example of each.
- States why finishing a course and restricting use follow from selection rather than from tolerance.
1 · Read
A good antibiotic is a difference detector. It hits something the microbe needs that you lack or build differently. Beta-lactams such as penicillin jam the enzymes that crosslink the wall, so growing cells burst, and your cells never notice because they make no peptidoglycan wall. Other classes sit on the bacterial ribosome and garble protein building, or starve folate synthesis. That gap between microbe and host is called selective toxicity.
Resistance travels four roads. Microbes can destroy the drug, as beta-lactamase enzymes do by snipping the beta-lactam ring. They can pump the drug out, the common answer to tetracyclines. They can bar entry, for example by losing the OprD porin that carbapenems use to enter. Or they can rework the target itself, such as an altered penicillin-binding protein that the drug can no longer grip.
Picture a ward where a broad-spectrum drug clears both the infection and the gut guard. With the resident microbes gone, a resistant squatter such as Clostridioides difficile blooms into a second infection. That superinfection is why a narrow drug aimed at the known pathogen beats a wide one sprayed blindly.
The drug never teaches resistance, it selects. Mutations and shared genes already vary the crowd, and the drug kills the susceptible while the resistant stand. Finishing the course denies survivors, and narrow careful use keeps pressure off every bystander microbe.
Hit what microbes have and you lack, and use drugs narrowly because every dose selects the resistant.
More to read
14.2 Fundamentals of Antimicrobial Chemotherapy
A useful drug is a difference detector. It must hit something the pathogen depends on that we either lack or build differently: the peptidoglycan wall, the bacterial ribosome, the folate pathway we skip by eating vitamins. Selectivity is never absolute, which is where side effects come from, but the wider the biological gap, the safer the drug. Every drug class maps to one such gap, and understanding the gap predicts both the killing and the collateral harm.
14.3 Mechanisms of Antibacterial Drugs
Antibacterial drugs sort neatly by target. Beta lactams jam the enzymes that crosslink the wall, so growing cells burst. Aminoglycosides and tetracyclines sit on the bacterial ribosome and garble translation. Sulfa drugs starve folate synthesis. Antifungals, antivirals, and antiparasitics each exploit their own kingdom specific gaps, which is why an antibacterial cannot touch a virus: the target simply is not there.
14.5 Drug Resistance
Resistance is evolution observed in real time, and it runs on selection, not intent. Enzymes that chew up penicillin, pumps that eject tetracycline, porin losses that bar entry, reworked targets that no longer bind: the variants arise by mutation and transfer, and the drug enriches whichever survives. That logic dictates policy. Finishing a course denies survivors, and reserving drugs narrows the selection pressure that would otherwise breed resistance in every bystander microbe.
Explore more
2 · Watch
Take it off screen
Where it sits
Learn first
Optional connections
This opens up
Nothing builds on it yet.
8 questions wait behind this lesson, each with its answer explained. Every answer feeds the sky: stars light as they are learned, and dim when it is time to come back.